Aardvark Therapeutics Statistics
Total Valuation
AARD has a market cap or net worth of $301.95 million. The enterprise value is $212.33 million.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
AARD has 21.38 million shares outstanding. The number of shares has increased by 2.06% in one year.
| Current Share Class | 21.38M |
| Shares Outstanding | 21.38M |
| Shares Change (YoY) | +2.06% |
| Shares Change (QoQ) | +0.49% |
| Owned by Insiders (%) | 14.35% |
| Owned by Institutions (%) | 4.62% |
| Float | 12.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.65 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 31.65, with a Debt / Equity ratio of 0.01.
| Current Ratio | 31.65 |
| Quick Ratio | 31.53 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -19.19% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$769,444 |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 424,651 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.57M |
| Pretax Income | -13.85M |
| Net Income | -13.85M |
| EBITDA | n/a |
| EBIT | -15.57M |
| Earnings Per Share (EPS) | -$3.49 |
Full Income StatementBalance Sheet
The company has $82.36 million in cash and $868,000 in debt, giving a net cash position of $81.49 million or $3.81 per share.
| Cash & Cash Equivalents | 82.36M |
| Total Debt | 868,000 |
| Net Cash | 81.49M |
| Net Cash Per Share | $3.81 |
| Equity (Book Value) | 80.58M |
| Book Value Per Share | -11.38 |
| Working Capital | 80.05M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$11.52 million and capital expenditures -$103,000, giving a free cash flow of -$11.62 million.
| Operating Cash Flow | -11.52M |
| Capital Expenditures | -103,000 |
| Free Cash Flow | -11.62M |
| FCF Per Share | -$0.54 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |